Cargando…
Managing dialysis patients who develop anemia caused by chronic kidney disease: focus on peginesatide
Anemia in chronic kidney disease is a prevalent and expensive problem in the United States, and it is well documented that anemia worsens as glomerular filtration rates decline. The complications of severe anemia in this patient population contribute significantly to their overall morbidity with inc...
Autores principales: | Valliant, Amanda, Hofmann, R Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3767492/ https://www.ncbi.nlm.nih.gov/pubmed/24023516 http://dx.doi.org/10.2147/IJN.S44944 |
Ejemplares similares
-
Profile of peginesatide and its potential for the treatment of anemia in adults with chronic kidney disease who are on dialysis
por: Mikhail, Ashraf
Publicado: (2012) -
Lessons learned from peginesatide in the treatment of anemia associated with chronic
kidney disease in patients on dialysis
por: Kaushik, Tarun, et al.
Publicado: (2013) -
A Population Pharmacokinetic and Pharmacodynamic Analysis of Peginesatide in Patients with Chronic Kidney Disease on Dialysis
por: Naik, Himanshu, et al.
Publicado: (2013) -
An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients
por: Besarab, Anatole, et al.
Publicado: (2012) -
Effects of Peginesatide Injection on QTc Interval in Healthy Adults
por: Czerniak, Richard, et al.
Publicado: (2014)